Recombinant Human CDKN2AIPNL

Recombinant Human CDKN2AIPNL

Pida mas información

935106861

info@markelab.com

Precio

Precio a consultar

Proteins CDKN2AIPNL

proveedor

FineTest

reference

P6429

Tested Applications

Western Blot,ELISA

reactivity

status

RUO

clonality

Características del producto

category

Proteins and Peptides


origin

Human


host

E.Coli


immunogen target

1-116


host

E.Coli


form

Lyophilized from a 0.2um filtered solution in PBS with 5% trehalose, pH7.4


tested applications

Western Blot,ELISA


size 1

50μg


size 2

200μg


size 3

1mg


observerd MW

12.7 kDa


expression

Recombinant


purity

Greater than 95% by SDS-PAGE gel analyses


purification

His tag


buffer

Reconstitute with Sterile distilled water


storage

-20°C for 12 months as lyophilized;2-8°C for 1 month under sterile conditions after reconstitution


or code

CDKN2AIPNL


availability

3-4 weeks


alias

C2AIL, C2AIL_HUMAN, CDKN2A interacting protein N terminal like, CDKN2A interacting protein N terminal like protein, CDKN2A-interacting protein N-terminal-like protein, CDKN2AIP N terminal like protein, CDKN2AIP N-terminal-like protein, Cdkn2aipnl


note

This product is for research use only.


Quizá le pueda interesar

Recombinant Human CDKN2AIPNL

Recombinant Human CDKN2AIPNL

proveedor

FineTest

reference

P6429

Tested Applications

Western Blot,ELISA

status

RUO

Precio a consultar

Ver más

CDKN2AIP N-Terminal-Like Protein (CDKN2AIPNL) Antibody

CDKN2AIP N-Terminal-Like Protein (CDKN2AIPNL) Antibody

proveedor

Abbexa

reference

abx109637

Tested Applications

ELISA, IHC

reactivity

Human

status

RUO

clonality

Polyclonal

CDKN2AIP N-terminal-like protein Antibody is a Rabbit Polyclonal antibody against CDKN2AIP N-terminal-like protein.

169€ (20 µg)

Ver más

CDKN2A Interacting Protein N-Terminal Like Protein

CDKN2A Interacting Protein N-Terminal Like Protein

proveedor

Abbexa

reference

abx263407

Tested Applications

SDS-PAGE

status

RUO

CDKN2AIPNL is a recombinant protein.

234€ (2 µg)

Ver más